D-0497-2025 Class II

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0497-2025 was initiated by Zydus Pharmaceuticals (USA) Inc on May 30, 2025 and is designated Class II. Reason for recall: Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents. Affected quantity: 11,616 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 18, 2025
Initiation Date
May 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,616 bottles

Product description

Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.

Reason for recall

Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.

Distribution pattern

IL, PA, & MS

Code information

Lot #s: B237040, B237041, Exp 10/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0497-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0497-2025. Report a data issue: hello@regdatalab.com.